'Self-protection' of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Guan, Yongjun ^a   Abdelwahab, Sayed ^a,b   Kamin Lewis, Roberta ^a   DeVico, Anthony L ^a   Lewis, George K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Minia University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; LIGAND;

ARTICLE; AUTOCRINE EFFECT; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL PROTECTION; CELL SECRETION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1 R5; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION PREVENTION; NONHUMAN; PROTEIN SYNTHESIS; VIRUS STRAIN; CELL CULTURE; GENETIC SELECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOLOGY; METABOLISM; PARACRINE SIGNALING; SPECIES DIFFERENCE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AUTOCRINE COMMUNICATION; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY; LIGANDS; PARACRINE COMMUNICATION; RECEPTORS, CCR5; SELECTION (GENETICS); SPECIES SPECIFICITY;

EID: 55649090743     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003481     Document Type: Article

References (43)

1. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, et al. (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815.
2. DeVico AL, Gallo RC (2004) Control of HIV-1 infection by soluble factors of the immune response. Nat Rev Microbiol 2: 401-413.
3. Paxton WA, Liu R, Kang S, Wu L, Gingeras TR, et al. (1998) Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines. Virology 244: 66-73.
4. Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, et al. (1998) C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci U S A 95: 3857-3861.
5. Wasik TJ, Bratosiewicz J, Wierzbicki A, Whiteman VE, Rutstein RR, et al. (1999) Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol 162: 4355-4364.
6. Garzino-Demo A, Moss RB, Margolick JB, Cleghorn F, Sill A, et al. (1999) Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status. Proc Natl Acad Sci U S A 96: 11986-11991.
7. Cocchi F, DeVico AL, Yarchoan R, Redfield R, Cleghorn F, et al. (2000) Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection. Proc Natl Acad Sci U S A 97: 13812-13817.
8. Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, et al. (2001) Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A 98: 5199-5204.
9. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, et al. (2005) The influence of CCL3L1 gene-containing segmental duplications on HIV-1/ AIDS susceptibility. Science 307: 1434-1440.
10. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, et al. (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2: 1240-1243.
11. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, et al. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381: 667-673.
12. Paxton WA, Kang S, Liu R, Landau NR, Gingeras TR, et al. (1999) HIV-1 infectability of CD4+ lymphocytes with relation to beta-chemokines and the CCR5 coreceptor. Immunol Lett 66: 71-75.
13. Paxton WA, Neumann AU, Kang S, Deutch L, Brown RC, et al. (2001) RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression. J Infect Dis 183: 1678-1681.
14. Kamin-Lewis R, Abdelwahab SF, Trang C, Baker A, DeVico AL, et al. (2001) Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta. Proc Natl Acad Sci U S A 98: 9283-9288.
15. Sun L, Abdelwahab SF, Lewis GK, Garzino-Demo A (2004) Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization. Int Immunol 16: 1623-1631.
16. De Rosa SC, Lu FX, Yu J, Perfetto SP, Falloon J, et al. (2004) Vaccination in humans generates broad T cell cytokine responses. J Immunol 173: 5372-5380.
17. Casazza JP, Betts MR, Price DA, Precopio ML, Ruff LE, et al. (2006) Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med 203: 2865-2877.
18. Abdelwahab SF, Cocchi F, Bagley KC, Kamin-Lewis R, Gallo RC, et al. (2003) HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses. Proc Natl Acad Sci U S A 100: 15006-15010.
19. Bagley KC, Abdelwahab SF, Tuskan RG, Fouts TR, Lewis GK (2002) Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway. J Leukoc Biol 72: 962-969.
20. Bagley KC, Abdelwahab SF, Tuskan RG, Fouts TR, Lewis GK (2002) Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway. Infect Immun 70: 5533-5539.
21. Bagley KC, Abdelwahab SF, Tuskan RG, Lewis GK (2005) Pasteurella multocida toxin activates human monocyte-derived and murine bone marrow-derived dendritic cells in vitro but suppresses antibody production in vivo. Infect Immun 73: 413-421.
22. Buonaguro L, Tornesello ML, Tagliamonte M, Gallo RC, Wang LX, et al. (2006) Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J Virol 80: 9134-9143.
23. Riley JL, Levine BL, Craighead N, Francomano T, Kim D, et al. (1998) Naive and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis. J Virol 72: 8273-8280.
24. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, et al. (1995) CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 95: 2061-2066.
25. Criado G, Madrenas J (2004) Superantigen stimulation reveals the contribution of Lck to negative regulation of T cell activation. J Immunol 172: 222-230.
26. Bueno C, Lemke CD, Criado G, Baroja ML, Ferguson SS, et al. (2006) Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway. Immunity 25: 67-78.
27. Selin LK, Welsh RM (2004) Plasticity of T cell memory responses to viruses. Immunity 20: 5-16.
28. Douek DC, Picker LJ, Koup RA (2003) T cell dynamics in HIV-1 infection. Annu Rev Immunol 21: 265-304.
29. Roederer M, De Rosa SC, Watanabe N, Herzenberg LA (1997) Dynamics of fine T-cell subsets during HIV disease and after thymic ablation by mediastinal irradiation. Semin Immunol 9: 389-396.
30. Moore JP, Kitchen SG, Pugach P, Zack JA (2004) The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 20: 111-126.
31. Lederman MM, Penn-Nicholson A, Cho M, Mosier D (2006) Biology of CCR5 and its role in HIV infection and treatment. Jama 296: 815-826.
32. Sabbe R, Picchio GR, Pastore C, Chaloin O, Hartley O, et al. (2001) Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression. J Virol 75: 661-671.
33. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, et al. (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature 417: 95-98.
34. Oswald-Richter K, Grill SM, Leelawong M, Tseng M, Kalams SA, et al. (2007) Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection. PLoS Pathog 3: e58.
35. Chun TW, Finzi D, Margolick J, Chadwick K, Schwartz D, et al. (1995) In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat Med 1: 1284-1290.
36. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, et al. (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387: 183-188.
37. Chun TW, Engel D, Berrey MM, Shea T, Corey L, et al. (1998) Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A 95: 8869-8873.
38. Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, et al. (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5: 512-517.
39. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, et al. (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278: 1295-1300.
40. Pierson T, McArthur J, Siliciano RF (2000) Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 18: 665-708.
41. Pierson T, Hoffman TL, Blankson J, Finzi D, Chadwick K, et al. (2000) Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1. J Virol 74: 7824-7833.
42. Mosier DE, Picchio GR, Gulizia RJ, Sabbe R, Poignard P, et al. (1999) Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J Virol 73: 3544-3550.
43. Letvin NL, Mascola JR, Sun Y, Gorgone DA, Buzby AP, et al. (2006) Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312: 1530-1533.